10:33 AM EDT, 05/14/2024 (MT Newswires) -- (Updates with bond value in the first paragraph and headline as well as additional details in the third paragraph)

Novo Nordisk ( NVO ) is selling 4.65 billion euros ($5.03 billion) in bonds, a first in more than two years, to finance programs to increase production of its blockbuster treatments, Bloomberg reported on Monday, citing a person familiar with the matter.

The company is issuing bonds for general corporate purposes and to finance the acquisition of the three sites from Catalent ( CTLT ), Novo Nordisk ( NVO ) told MT newswires.

The company on Tuesday offered for sale two euro-denominated bonds in a debt offering with maturity periods ranging from two to 10 years, the report added.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 131.97, Change: -0.44, Percent Change: -0.33